LUNG Pulmonx Corp — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$1.27

Period return

-0.64 (-33.51%)

Volume

414.0K

2026-07-21O $1.34 H $1.34 L $1.22 C $1.27MA5 $1.38MA20 $1.4MA60 $1.4MA120 $1.44

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 07. 29.Highin 8 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 15.High2 months ago
13F 기관 보유 변화 — TWO SIGMA INVESTMENTS, LP
신규 편입 · 포트폴리오 비중 0.00%
2026. 04. 30.LowBUY3 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.
2026. 03. 06.LowBUY5 months ago
Canaccord Genuity: Buy
US analyst rating / recommendation change.
2026. 03. 05.LowBUY5 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.
2026. 02. 20.LowBUY5 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.
2025. 11. 13.LowBUY8 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.
2025. 10. 29.LowBUY9 months ago
Lake Street: Buy
US analyst rating / recommendation change.
2025. 10. 28.LowBUY9 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.
2025. 09. 08.LowBUY11 months ago
D. Boral Capital: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $3.4 · 5 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Sector: Healthcare
Industry: Medical Devices
HQ: Redwood City, CA, United States
Fiscal year end

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 07. 29.	After market close (AMC)	$-0.28	—	—	$22.39M	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-0.36	—	—	$22.54M	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$-1.11	—	—	$60.02M	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$-0.75	—	—	$39.64M	Reported

#	Institution	Mandate	Shares	Value	Weight	Change	Position
1	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	132,770	$293.42K	0.00%	—	New position
2	TWO SIGMA INVESTMENTS, LP	TWO SIGMA INVESTMENTS, LP	68,612	$88.51K	0.00%	—	New position

Pulmonx Corp

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 04. 30.	D. Boral Capital	—	Maintain	Buy → Buy	—	D. Boral Capital: Buy
2026. 03. 06.	Canaccord Genuity	—	Maintain	Buy → Buy	—	Canaccord Genuity: Buy
2026. 03. 05.	D. Boral Capital	—	Maintain	Buy → Buy	—	D. Boral Capital: Buy
2026. 02. 20.	D. Boral Capital	—	Maintain	Buy → Buy	—	D. Boral Capital: Buy
2025. 11. 13.	D. Boral Capital	—	Maintain	Buy → Buy	—	D. Boral Capital: Buy
2025. 10. 29.	Lake Street	—	Maintain	Buy → Buy	—	Lake Street: Buy